Trial
NCT00480935
A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Health Network, Toronto
Collaborators
Pfizer
Condition
Renal Cell Carcinoma
Intervention
Sunitinib Malate (Sutent)
Why stopped
poor recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-12-09